LORIA, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.527
EU - Europa 8.070
AS - Asia 7.934
SA - Sud America 948
AF - Africa 92
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 9
Totale 37.599
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.413
GB - Regno Unito 3.081
CN - Cina 2.909
SG - Singapore 2.348
HK - Hong Kong 1.312
IT - Italia 1.157
SE - Svezia 955
DE - Germania 928
BR - Brasile 804
UA - Ucraina 548
TR - Turchia 502
RU - Federazione Russa 372
FI - Finlandia 348
KR - Corea 258
BG - Bulgaria 207
FR - Francia 192
VN - Vietnam 191
IN - India 83
AR - Argentina 55
JP - Giappone 49
ID - Indonesia 48
NL - Olanda 48
CA - Canada 47
BD - Bangladesh 46
MX - Messico 46
BE - Belgio 31
PL - Polonia 29
ES - Italia 28
ZA - Sudafrica 26
LT - Lituania 24
IQ - Iraq 23
AT - Austria 22
EC - Ecuador 21
MY - Malesia 21
PK - Pakistan 21
CZ - Repubblica Ceca 19
IE - Irlanda 19
TW - Taiwan 17
AE - Emirati Arabi Uniti 14
IR - Iran 14
PY - Paraguay 14
RO - Romania 14
VE - Venezuela 14
CL - Cile 13
MA - Marocco 13
AU - Australia 11
UZ - Uzbekistan 11
CO - Colombia 9
CH - Svizzera 8
EG - Egitto 8
JO - Giordania 8
BO - Bolivia 7
ET - Etiopia 7
EU - Europa 7
NZ - Nuova Zelanda 7
PE - Perù 7
SI - Slovenia 7
TN - Tunisia 7
AZ - Azerbaigian 5
BA - Bosnia-Erzegovina 5
GE - Georgia 5
KE - Kenya 5
KZ - Kazakistan 5
NP - Nepal 5
OM - Oman 5
PH - Filippine 5
SA - Arabia Saudita 5
SC - Seychelles 5
BY - Bielorussia 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
HU - Ungheria 4
IL - Israele 4
JM - Giamaica 4
UG - Uganda 4
AL - Albania 3
CY - Cipro 3
GR - Grecia 3
HN - Honduras 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
NG - Nigeria 3
NO - Norvegia 3
QA - Qatar 3
RS - Serbia 3
TH - Thailandia 3
UY - Uruguay 3
GH - Ghana 2
GT - Guatemala 2
KW - Kuwait 2
LV - Lettonia 2
PA - Panama 2
SN - Senegal 2
TJ - Tagikistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
Totale 37.585
Salva come PNG Salva come JPEG
Città #
Fairfield 2.189
Southend 2.017
Santa Clara 1.935
Woodbridge 1.601
Ashburn 1.504
Singapore 1.489
Hong Kong 1.307
Houston 1.290
Jacksonville 1.223
Chandler 1.197
Hefei 1.150
Seattle 837
Dearborn 796
Wilmington 783
Ann Arbor 776
Cambridge 720
Nyköping 546
London 510
Beijing 473
Chicago 339
Modena 305
Los Angeles 295
Izmir 285
Seoul 245
San Diego 235
Princeton 220
Sofia 207
Eugene 201
New York 194
Des Moines 166
Munich 139
Salt Lake City 126
Moscow 123
Shanghai 120
Helsinki 113
Buffalo 106
Grafing 101
Council Bluffs 91
Falls Church 86
São Paulo 81
The Dalles 78
Columbus 77
Tampa 77
Dallas 76
Ho Chi Minh City 72
Elk Grove Village 68
Rome 65
Bremen 58
Milan 57
Kunming 48
Hanoi 45
Guangzhou 43
Boardman 42
Istanbul 40
Redwood City 39
Turku 38
Jakarta 36
Sterling 36
Norwalk 35
San Mateo 33
Fremont 32
Kent 31
Bologna 30
Rio de Janeiro 30
Brussels 27
Phoenix 27
San Francisco 27
Tokyo 27
Lancaster 25
Miami 25
Kilburn 23
Warsaw 23
Frankfurt am Main 22
Brooklyn 20
Denver 20
Nanjing 20
Jinan 19
Verona 19
Bari 18
Hounslow 18
Poplar 18
Dongguan 17
Dulles 17
Toronto 17
Dublin 16
Nanchang 16
Atlanta 15
Belo Horizonte 15
Nuremberg 15
Parma 15
Stockholm 15
Zhengzhou 15
Brno 14
Chiswick 14
Johannesburg 14
Mexico City 14
Manchester 13
Montreal 13
Redondo Beach 13
Vienna 13
Totale 27.966
Salva come PNG Salva come JPEG
Nome #
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 386
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 355
Gender, fatty liver and GGT 336
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 324
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 321
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 315
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 309
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 308
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 303
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 302
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 302
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 295
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 294
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 293
Review article: diabetes, genetics and ethnicity 292
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 279
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 269
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 263
Endocrine and liver interaction: the role of endocrine pathways in NASH 262
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 259
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 258
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 255
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 254
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 248
Nonalcoholic fatty liver disease and aging: epidemiology to management 248
Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD 244
Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis. 243
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 242
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 241
Treatment of atherogenic liver based on the pathogenesis of nonalcoholic Fatty liver disease: a novel approach to reduce cardiovascular risk? 240
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. 240
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 239
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 238
Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis 237
Liver and kidney foreign bodies granulomatosis in a patient with malocclusion, bruxism, and worn dental prostheses 236
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. 236
Chicken or egg turned into head or belly 235
Effect of the selective expansion of cholic acid pool on bile lipid composition: possible mechanism of bile acid induced biliary cholesterol desaturation. 234
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. 234
Apolipoprotein synthesis in nonalcoholic steatohepatitis 233
Advances in the comprehension of the pathophysiology of bile secretion 232
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis 229
Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD) 229
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 228
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 228
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? 226
Statins in liver disease: a molehill, an iceberg, or neither? 226
Anatomia e fisiologia delle vie biliari 226
If steatosis is the atherosclerosis of the liver, are statins the "aspirin" for steatosis? 225
'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis 224
Risk factors for hospital readmission of elderly patients 222
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 218
Effects of acute changes of bile acid pool composition on biliary lipid secretion 215
Determinants of bile secretion: effect of bile salt structure on bile flow and biliary cation secretion 215
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question 214
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 213
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 212
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 212
Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms. 212
Review article: hepatic steatosis and insulin resistance 212
MR techniques in the qualitative analysis of liver steatosis: the potential in the differentiation between steatohepatatis and steatosis 211
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 211
Patogenesi della colelitiasi. I. Colelitiasi colesterinica. 210
From NAFLD in clinical practice to answers from guidelines. 210
Clinical physiology of NAFLD: A critical overview of pathogenesis and treatment 209
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project) 208
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 207
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study. 207
Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid. 206
Bile acid structure and regulation of biliary protein secretion and composition in man 206
Cardiovascular and systemic risk in nonalcoholic fatty liver disease -Atherosclerosis as a major player in the natural course of NAFLD 206
Growth hormone plasma levels in nonalcoholic fatty liver disease 205
Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B. 205
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? 204
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 202
Multiecho MR sequences and high-resolution magic angle spinning (HRMAS)ex-vivo spectroscopy in the qualitative analysis and differentiationbetween steatohepatitis and steatosis 202
Hepatitis C and diabetes: the inevitable coincidence? 201
Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short erm feeding of chenodeoxycholic and ursodeoxycholic acid 198
Effect of ursocholic acid on bile lipid secretion and composition 198
NAFLD and cardiovascular risk: direct evidence for the tale of two ages. 197
Cholesterol absorption in cirrhosis: the role of total and individual bile acid pool size 197
The effect of chenodeoxycholic acid (CDCA) on cholesterol absorption. 196
Bile acid composition and hepatic sterol metabolism in man. The effect of deoxycholic acid administration. 194
Diet and gallstones in Italy: the cross-sectional MICOL results. 194
Statins and HCV: a complex issue 194
Influence of age and sex on serum concentrations of total dimeric activin A 193
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 193
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 193
Non-alcoholic Fatty Liver Disease: a HR-MAS analysis 192
Relationship of serum fetuin-a levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography. 192
The hepatitis C virus-associated dysmetabolic syndrome. 191
Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient - death of a dogma from analysis of therapeutic studies? 190
Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus - A prospective, double-blind, randomized study 189
Fisiologia della secrezione biliare. 188
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. 188
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 188
Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease 187
The prediction of coronary heart disease mortality as a function of major risk factors in over 30.000 men in the italian RIFLE Pooling Project. A comparison with the MRFIT primary screenees 185
MR techiniques in the quantitative assessment of liver steatosis 184
Short-term effects of simvastatin on bile acid synthesis and biliary lipid secretion in human subjects. 183
Totale 23.234
Salva come PNG Salva come JPEG
Categoria #
all - tutte 157.847
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 157.847
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.587 0 0 0 0 391 294 369 545 133 452 257 146
2021/20223.583 51 502 394 313 87 156 261 204 392 213 607 403
2022/20233.279 363 354 205 326 401 583 72 310 385 29 142 109
2023/20242.003 84 119 114 136 457 221 216 286 56 42 75 197
2024/20257.463 263 87 129 495 1.607 971 588 413 707 257 838 1.108
2025/20265.871 897 613 1.224 1.896 1.241 0 0 0 0 0 0 0
Totale 37.751